AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Dermapharm Holding SE

Report Publication Announcement Aug 18, 2025

97_rns_2025-08-18_b3b415be-fa1f-4878-9e60-bdec42465578.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

News Details

Advance financial reports | 18 August 2025 09:26

Dermapharm Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

Dermapharm Holding SE / Preliminary announcement on the disclosure of financial statements

Dermapharm Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

18.08.2025 / 09:26 CET/CEST

Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News – a service of EQS Group.

The issuer is solely responsible for the content of this announcement.


Dermapharm Holding SE hereby announces that the following financial reports shall be disclosed:

Report Type: Financial report of the group (half-year/Q2)

Language: German

Date of disclosure: August 26, 2025

Address: https://ir.dermapharm.de/de/investor-relations/finanzberichte-praesentationen/

Language: English

Date of disclosure: August 26, 2025

Address: https://ir.dermapharm.de/en/investor-relations/financial-reports-presentations/


18.08.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com


Language: English
Company: Dermapharm Holding SE
Lil-Dagover-Ring 7
82031 Grünwald
Germany
Internet: ir.dermapharm.de
End of News EQS News Service

2185080  18.08.2025 CET/CEST

Talk to a Data Expert

Have a question? We'll get back to you promptly.